Principal components analysis on genes related to inflammasome complex and microglial activation in the hypothalamus of obese mice treated with semaglutide (GLP-1 analog).
在接受semaglutide(GLP-1 類似物)治療的肥胖小鼠下丘腦中,與炎症小體複合體和小膠質細胞活化相關基因的主成分分析。
Brain Res 2024-09-07
Phosphorylated proteomics-based analysis of the effects of semaglutide on hippocampi of high-fat diet-induced-obese mice.
Semaglutide對高脂飲食誘導肥胖小鼠海馬迴的磷酸化蛋白質組學分析。
Diabetol Metab Syndr 2023-04-03
Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796.
NLRP3 Inflammasome 抑制劑 NT-0249 和 NT-0796 逆轉高脂飲食誘導的肥胖、全身性發炎和星形膠質增生。
J Pharmacol Exp Ther 2024-03-13
Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis.
Semaglutide 減輕焦慮和抑鬱樣行為,並通過微生物-腸-大腦軸逆轉 2 型糖尿病小鼠模型中的認知障礙。
J Neuroimmune Pharmacol 2024-07-23
Semaglutide Alleviates Ovary Inflammation via the AMPK/SIRT1/NF‑κB Signaling Pathway in Polycystic Ovary Syndrome Mice.
Semaglutide 透過 AMPK/SIRT1/NF‑κB 信號通路減輕多囊卵巢症候群小鼠的卵巢炎症。
Drug Des Devel Ther 2024-09-09